QuantaLife Closes $17.2M Series B Round to Back Upcoming Launch of Droplet Digital PCR Platform

Paladin Capital Group and other existing investors participated, as well as new investors Vital Financial and Mérieux Développement, the healthcare investment company of Institut Mérieux, which counts among its subsidiaries diagnostic firm BioMérieux.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.